How to buy Pfizer shares

Pfizer shares have fallen -2.29% from yesterday's closing price ($32.85). Learn how to easily invest in Pfizer shares in the UK.

Global stock markets soared in response to the news that American pharmaceuticals company Pfizer (PFE) has developed a vaccine, tested on 43,500 people, which it claims is 90% effective.

On the day of the announcement, Pfizer's share price rose 15%, before falling back and closing 7% up on the previous day. Other industries reacted positively to the news, with global economic hopes seemingly pinned on the vaccine.

How to buy shares in Pfizer

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: PFE in this case.
  5. Research Pfizer shares. The platform should provide the latest information available.
  6. Buy your Pfizer shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.
Our top picks for where to buy Pfizer shares:

Best for

Beginner investments

IG Share Dealing image

Fees for buying 20x Pfizer shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Customer rating Platform fee Min. initial deposit Trading fee estimate
Freetrade logo ★★★★★ £0 - £9.99 No minimum £3.17
£539.74 total
Capital at risk
eToro Free Stocks logo ★★★★★ £0 $50 £2.68
£539.25 total
Capital at risk
IG Share Dealing logo ★★★★★ £0 £250 £10.89
£547.46 total
Capital at risk
XTB logo Not yet rated £0 No minimum £2.68
£539.25 total
Capital at risk
CMC Invest share dealing account logo Not yet rated £0 No minimum £2.68
£539.25 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo ★★★★★ £0 £1 £17.32
£553.89 total
Capital at risk
Lightyear logo Not yet rated £0 No minimum £1.96
£538.53 total
Capital at risk

Full comparison of share dealing platforms

These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Alternative ways to invest in Pfizer

Is it a good time to buy Pfizer stock?

Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Promoted
eToro Free Stocks

Invest in Pfizer shares
Finder Award

  • Start investing from $50
  • Pay no stamp duty on UK shares
  • Commission-free trading. Other fees may apply.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Pfizer under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Pfizer P/E ratio, PEG ratio and EBITDA

Pfizer's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Pfizer shares trade at around 9x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, Pfizer's P/E ratio is best considered in relation to those of others within the drug manufacturers-general industry or those of similar companies.

Pfizer's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1729. A PEG ratio close to 1 can be interpreted as meaning shares offer reasonable value for the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Pfizer's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

However, it's sensible to consider Pfizer's PEG ratio in relation to those of similar companies.

Pfizer's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $31.1 billion (£25.4 billion).

The EBITDA is a measure of a Pfizer's overall financial performance and is widely used to measure a its profitability.

To put that into context you can compare it against similar companies.

What's Pfizer's ESG track record?

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Pfizer.

Overall Pfizer ESG score

Pfizer's total ESG risk: 33.15

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Pfizer's overall score of 33.15 (as at 01/01/2019) is pretty weak – landing it in it in the 60th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Pfizer is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

To gain some more context, you can compare Pfizer's total ESG risk score against those of similar companies.

Pfizer's environmental score: 7/100

Pfizer's environmental score of 7 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Pfizer is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Pfizer's social score: 18.47/100

Pfizer's social score of 18.47 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Pfizer is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Pfizer's governance score: 13.68/100

Pfizer's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Pfizer is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Pfizer's controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Pfizer scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Pfizer hasn't always managed to keep its nose clean.

Wondering how that compares? Below are the controversy scores of similar companies.

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

  • How to buy Exelixis shares

    Ever wondered how to buy shares in Exelixis? We explain how and compare a range of providers that can give you access to many brands, including Exelixis.

  • How to buy Five Star Senior Living shares

    Ever wondered how to buy shares in Five Star Senior Living? We explain how and compare a range of providers that can give you access to many brands, including Five Star Senior Living.

  • How to buy Community Health Systems shares

    Ever wondered how to buy shares in Community Health Systems? We explain how and compare a range of providers that can give you access to many brands, including Community Health Systems.

  • How to buy Chiasma shares

    Ever wondered how to buy shares in Chiasma? We explain how and compare a range of providers that can give you access to many brands, including Chiasma.

  • How to buy Healthcare Services Group shares

    Ever wondered how to buy shares in Healthcare Services Group? We explain how and compare a range of providers that can give you access to many brands, including Healthcare Services Group.

  • How to buy Catalent shares

    Ever wondered how to buy shares in Catalent? We explain how and compare a range of providers that can give you access to many brands, including Catalent.

  • How to buy Aytu BioScience shares

    Ever wondered how to buy shares in Aytu BioScience? We explain how and compare a range of providers that can give you access to many brands, including Aytu BioScience.

  • How to buy bluebird bio shares

    Ever wondered how to buy shares in bluebird bio? We explain how and compare a range of providers that can give you access to many brands, including bluebird bio.

  • How to buy LHC Group shares

    Ever wondered how to buy shares in LHC Group? We explain how and compare a range of providers that can give you access to many brands, including LHC Group.

  • How to buy Amneal Pharmaceuticals shares

    Ever wondered how to buy shares in Amneal Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Amneal Pharmaceuticals.

Go to site